These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 9316639
1. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Kundu N, Fulton AM. Cell Immunol; 1997 Aug 25; 180(1):55-61. PubMed ID: 9316639 [Abstract] [Full Text] [Related]
2. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells. Tsuruma T, Yagihashi A, Torigoe T, Sato N, Kikuchi K, Watanabe N, Hirata K. Cell Immunol; 1998 Mar 15; 184(2):121-8. PubMed ID: 9630838 [Abstract] [Full Text] [Related]
3. Interleukin-10 reduces natural killer (NK) sensitivity of tumor cells by downregulating NK target structure expression. Tsuruma T, Yagihashi A, Hirata K, Torigoe T, Araya J, Watanabe N, Sato N. Cell Immunol; 1999 Dec 15; 198(2):103-10. PubMed ID: 10648124 [Abstract] [Full Text] [Related]
5. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro. Kijima M, Saio M, Oyang GF, Suwa T, Miyauchi R, Kojima Y, Imai H, Nakagawa J, Nonaka K, Umemura N, Nishimura T, Takami T. Int J Oncol; 2005 Mar 15; 26(3):679-84. PubMed ID: 15703823 [Abstract] [Full Text] [Related]
8. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules. Kubota A, Lian RH, Lohwasser S, Salcedo M, Takei F. J Immunol; 1999 Dec 15; 163(12):6488-93. PubMed ID: 10586040 [Abstract] [Full Text] [Related]
10. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma. Nishimura MI, Stroynowski I, Hood L, Ostrand-Rosenberg S. J Immunol; 1988 Dec 15; 141(12):4403-9. PubMed ID: 3264312 [Abstract] [Full Text] [Related]
12. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene. Gorelik E, Jay G, Kwiatkowski B, Herberman RB. J Immunol; 1990 Sep 01; 145(5):1621-32. PubMed ID: 2384672 [Abstract] [Full Text] [Related]
14. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Lee JM, Mahtabifard A, Yamada R, Crystal RG, Korst RJ. Clin Cancer Res; 2002 Nov 01; 8(11):3561-9. PubMed ID: 12429647 [Abstract] [Full Text] [Related]
16. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S, Yamauchi H, Hiroishi K, Takeda K, Tagawa Y, Iwakura Y, Kayagaki N, Kurimoto M, Okamura H, Hada T, Yagita H, Akira S, Nakanishi K, Higashino K. J Immunol; 1999 Feb 01; 162(3):1662-8. PubMed ID: 9973427 [Abstract] [Full Text] [Related]
17. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Mammolenti M, Gajavelli S, Tsoulfas P, Levy R. Stem Cells; 2004 Feb 01; 22(6):1101-10. PubMed ID: 15536199 [Abstract] [Full Text] [Related]
18. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Nagashima S, Reichert TE, Kashii Y, Suminami Y, Chikamatsu K, Whiteside TL. Cancer Gene Ther; 1997 Feb 01; 4(6):366-76. PubMed ID: 9408607 [Abstract] [Full Text] [Related]
19. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z. Hum Immunol; 2008 Aug 01; 69(8):490-500. PubMed ID: 18619507 [Abstract] [Full Text] [Related]
20. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB, Phillips JH, Figdor CG, Lanier LL. J Immunol; 1998 Jun 01; 160(11):5239-45. PubMed ID: 9605119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]